Responsiveness of different MET tumour alterations to type I and type II MET inhibitors is a research paper published in Clinical and Translational Medicine (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: P30 CA008748
Woman's Cancer Association of the University of Miami
Grant: ACSP-2024-02
NCI/NIH
Grant: P30-CA240139
National Institutes of Health
Grant: 5K12CA184746-02
MSK Paul Calabresi Career Development Award for Clinical Oncology
National Institutes of Health
Grant: 3P30CA240139-02S3
The Sylvester Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA279264-02
Mechanisms of adaptation and resistance to emerging therapies for lung cancer
National Institutes of Health
Grant: 3UL1TR000457-08S1
Clinical and Translational Science Center
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
Madelon Ravlin Grant Memorial
Sylvester Comprehensive Cancer Center
Tumor biology intra-programmatic pilot award from the Sylvester Comprehensive Cancer Center
Lung Cancer Research Foundation
Nonna's Garden fund
NIH HHS
Dwoskin Family Foundation
National Institutes of Health
NIH
Fields of Study
MeSH Terms
Keywords